Oncoscience | October 4th, 2008
Oncoscience AG is a member of the German Funcrypta project. Within the scope of this cooperation a poster will be presen...
Oncoscience AG receives EU orphan drug status for the EGFR monoclonal antibody Nimotuzumab (Theraloc®) for the treatment of pancreatic cancer.
Oncoscience | April 22nd, 2008
Oncoscience AG announced that their anti-cancer drug Nimotuzumab (Theraloc®) has been designated an orphan drug by the ...